Lindsey Wahlstrom-Edwards

Clinical trial patient engagement in 2020: Measuring what matters most

The start of the new year always feels weighty: Who will I be in 2020? What will I achieve? Here’s one tone-setting question for us all to consider: What book will I read first? For an inspirational 2020 kickoff, we recommend David Fajgenbaum’s Chasing My Cure. 

Continue reading

Both Sides Now: Reflections from a Pharma Industry Professional and Cancer Survivor on True Patient Centricity

In 2014, Stacy Hurt was enjoying a booming career in the pharmaceutical company and life with her husband and eight- and ten-year-old sons. Though Stacy's life was not easy – her youngest son has, in her words, "profound disabilities", and requires around the clock care – her family was thriving.

Continue reading

Patient Advocacy Groups are Banding Together – Why That’s a Good Thing

Lindsey Wahlstrom-Edwards is Director of Partnerships and Distribution at Antidote. She works with health nonprofits and patient advocates to connect their communities with research.

Continue reading

Delivering on Diversity: How do we move the needle?

In our Delivering on Diversity series, we’ve spoken with Clinical Ambassador CEO and Founder Allison Kalloo about a variety of topics related to minority engagement in medical research.

Continue reading

Use Video to Grow Your Reach [On-Demand Webinar]

Video content is booming, especially on social media platforms like Facebook, where users now spend more time interacting with video than viewing text or image-based content. But knowing where to start and how to get the content right can be confusing.

Continue reading

Delivering on Diversity: Clinical Trials and Healthcare Access

Clinical trials help people access tomorrow’s treatments today. In the age of precision medicine and tumor profiling, this statement is particularly true for oncology patients. According to a recent ProPublica article, even in Phase I trials, 20% of clinical trial participants now see a reduction in tumor size, compared with 5% of participants in the 1990s.

Continue reading

Delivering on Diversity: Tuskegee and what it means for minority participation in medical research today

Every conversation about minority participation in medical research inevitably  winds up with the “T” word – Tuskegee.

Continue reading

Research Pioneers: Meet Allison Kalloo

At Antidote, we aim to make it easy for researchers and patients to connect. And a big part of that work is creating opportunities for people to learn more about medical research and dispelling myths about medical research participation, both for patients and researchers.

Continue reading

Experts Sound Off: Minority Participation in Medical Research

Increasingly, medical researchers acknowledge the need for more diversity in study participants so that trials can better predict the real-world impact of a drug or medical device. Yet a big question remains: How can researchers better reach diverse populations to drive minority participation in medical research?

Continue reading

Patient Advocates Weigh In: Why lupus clinical trials need more minority participants

Minority participation in medical research is important for all conditions, but is critical for ailments that disproportionately impact people of color, like lupus.

Continue reading

Get our latest posts in your inbox.